Mind the gap in kidney care: translating what we know into what we do

被引:0
作者
Luyckx, Valerie [1 ,2 ,3 ]
Tuttle, Katherine [4 ,5 ]
Abdellatif, Dina [6 ]
Correa-Rotter, Ricardo [7 ]
Fung, Winston W. S. [8 ]
Haris, Agnes [9 ]
Hsiao, L. L. [2 ]
Khalife, Makram [10 ]
Kumaraswami, Latha [11 ]
Loud, Fiona [10 ]
Raghavan, Vasundhara [10 ]
Roumeliotis, Stefanos [12 ]
Sierra, Marianella [10 ]
Ulasi, Ifeoma [13 ]
Wang, Bill [14 ]
Lui, S. F.
Liakopoulos, Vassilios [12 ]
Balducci, Alessandro [15 ]
机构
[1] Univ Zurich, Epidemiol Biostat & Prevent Inst, Dept Publ & Global Hlth, Zurich, Switzerland
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Renal Div, Boston, MA 02115 USA
[3] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa
[4] Providence Inland Northwest Hlth, Providence Med Res Ctr, Spokane, WA USA
[5] Univ Washington, Dept Med, Nephrol Div, Seattle, WA USA
[6] Cairo Univ Hosp, Dept Nephrol, Cairo, Egypt
[7] Natl Med Sci & Nutr Inst Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City, Mexico
[8] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Peoples R China
[9] Peterfy Hosp, Neurol Dept, Budapest, Hungary
[10] Int Soc Nephrol, Patient Liaison Advisory Grp, Brussels, Belgium
[11] Tamilnad Kidney Res Fdn, Chennai, India
[12] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Dept Nephrol 2, Med Sch, Thessaloniki, Greece
[13] Univ Nigeria, Coll Med, Dept Med, Ituku Ozalla, Enugu, Nigeria
[14] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Hlth Syst Policy & Management, Shatin, Hong Kong, Peoples R China
[15] Italian Kidney Fdn, Rome, Italy
关键词
MIDDLE-INCOME; DISEASE; CKD; MANAGEMENT; MEDICINES; BARRIERS; OUTCOMES; BURDEN; RISK;
D O I
10.12809/hkmj245162
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Historically, it takes an average of 17 years to move new treatments from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. The time is now to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common risk factors for kidney disease, such as hypertension and diabetes, but only a fraction of people worldwide with these conditions are diagnosed, and even fewer receive appropriate treatment. Similarly, the vast majority of people living with kidney disease are unaware of their condition, because in the early stages it is often silent. Even among diagnosed patients, many do not receive appropriate treatment for kidney disease. Considering the serious consequences of kidney disease progression, kidney failure, or death, it is imperative to initiate treatments early and appropriately. Opportunities to diagnose and treat kidney disease early must be maximised, starting at the primary care level. Many systematic barriers exist, encompassing patient, clinician, health system, and societal factors. To preserve and improve kidney health for everyone everywhere, each of these barriers must be acknowledged so that sustainable solutions are developed and implemented without further delay.
引用
收藏
页数:12
相关论文
共 67 条
  • [1] Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
    Agarwal, Rajiv
    Filippatos, Gerasimos
    Pitt, Bertram
    Anker, Stefan D.
    Rossing, Peter
    Joseph, Amer
    Kolkhof, Peter
    Nowack, Christina
    Gebel, Martin
    Ruilope, Luis M.
    Bakris, George L.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (06) : 474 - +
  • [3] The effect of pharmacist-led interventions on the management and outcomes in chronic kidney disease (CKD): A systematic review and meta-analysis protocol
    Ardavani, Ashkon
    Curtis, Ffion
    Khunti, Kamlesh
    Wilkinson, Thomas J.
    [J]. HEALTH SCIENCE REPORTS, 2023, 6 (01)
  • [4] Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
    Bikbov, Boris
    Purcell, Carrie
    Levey, Andrew S.
    Smith, Mari
    Abdoli, Amir
    Abebe, Molla
    Adebayo, Oladimeji M.
    Afarideh, Mohsen
    Agarwal, Sanjay Kumar
    Agudelo-Botero, Marcela
    Ahmadian, Elham
    Al-Aly, Ziyad
    Alipour, Vahid
    Almasi-Hashiani, Amir
    Al-Raddadi, Rajaa M.
    Alvis-Guzman, Nelson
    Amini, Saeed
    Andrei, Tudorel
    Andrei, Catalina Liliana
    Andualem, Zewudu
    Anjomshoa, Mina
    Arabloo, Jalal
    Ashagre, Alebachew Fasil
    Asmelash, Daniel
    Ataro, Zerihun
    Atout, Maha Moh'd Wahbi
    Ayanore, Martin Amogre
    Badawi, Alaa
    Bakhtiari, Ahad
    Ballew, Shoshana H.
    Balouchi, Abbas
    Banach, Maciej
    Barquera, Simon
    Basu, Sanjay
    Bayih, Mulat Tirfie
    Bedi, Neeraj
    Bello, Aminu K.
    Bensenor, Isabela M.
    Bijani, Ali
    Boloor, Archith
    Borzi, Antonio M.
    Camera, Luis Alberto
    Carrero, Juan J.
    Carvalho, Felix
    Castro, Franz
    Catala-Lopez, Ferran
    Chang, Alex R.
    Chin, Ken Lee
    Chung, Sheng-Chia
    Cirillo, Massimo
    [J]. LANCET, 2020, 395 (10225) : 709 - 733
  • [5] Patient Awareness of CKD: A Systematic Review and Meta-analysis of Patient-Oriented Questions and Study Setting
    Chu, Chi D.
    Chen, Michael H.
    McCulloch, Charles E.
    Powe, Neil R.
    Estrella, Michelle M.
    Shlipak, Michael G.
    Tuot, Delphine S.
    [J]. KIDNEY MEDICINE, 2021, 3 (04) : 576 - +
  • [6] AWAREness of Diagnosis and Treatment of Chronic Kidney Disease in Adults With Type 2 Diabetes (AWARE-CKD in T2D)
    Chu, Lisa
    Bhogal, Sanjit K.
    Lin, Peter
    Steele, Andrew
    Fuller, Mark
    Ciaccia, Antonio
    Abitbol, Alexander
    [J]. CANADIAN JOURNAL OF DIABETES, 2022, 46 (05) : 464 - 472
  • [7] Expectations in children with glomerular diseases from SGLT2 inhibitors
    Cirillo, Luigi
    Ravaglia, Fiammetta
    Errichiello, Carmela
    Anders, Hans-Joachim
    Romagnani, Paola
    Becherucci, Francesca
    [J]. PEDIATRIC NEPHROLOGY, 2022, 37 (12) : 2997 - 3008
  • [8] de Boer IH, 2022, KIDNEY INT, V102, pS1, DOI 10.1016/j.kint.2022.06.008
  • [9] Cost analysis of telemedicine use in paediatric nephrology-the LMIC perspective
    Dev, Vishnu
    Mittal, Aliza
    Joshi, Vibha
    Meena, Jitendra K.
    Dhanesh Goel, Akhil
    Didel, Siyaram
    Pareek, Puneet
    Misra, Sanjeev
    Singh, Kuldeep
    [J]. PEDIATRIC NEPHROLOGY, 2024, 39 (01) : 193 - 201
  • [10] Bridging the "Know-Do" Gaps in Five Non- Communicable Diseases Using a Common Framework Driven by Implementation Science
    Donohue, James F.
    Elborn, J. Stuart
    Lansberg, Peter
    Javed, Afzal
    Tesfaye, Solomon
    Rugo, Hope
    Duddi, Sita Ratna Devi
    Jithoo, Niraksha
    Huang, Pai-Hui
    Subramaniam, Kannan
    Ramanjinappa, Nagendra
    Koltun, Arkady
    Melamed, Shari
    Chan, Juliana C. N.
    [J]. JOURNAL OF HEALTHCARE LEADERSHIP, 2023, 15 : 103 - 119